BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

Unmatched expertise in patient recruitment and retentionOne of the critical challenges in clinical trials is patient ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

A global pharmaceutical company is moving into Center City next year — and it could be a “game-changing” development for Philly’s biotech scene, a leader in the space says. “We see it as a ...

Drug delivery is no longer just about convenience. It’s about enabling the therapies of the future to succeed where they ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as tomorrow’s science will evolve at the intersection of Biology and Artificial ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...